Evaluation of synthetic serum substitute versus serum as protein supplementation for mouse and human embryo culture
Synthetic serum substitute (SSS) supported superior mouse embryo development and comparable human embryo development to serum, with a trend towards better fertilization rates in SSS.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The study evaluated whether Synthetic Serum Substitute (SSS) can replace serum protein in embryo culture, comparing SSS with human serum in two experiments. In Experiment I, 1-cell mouse embryos were cultured with 15% protein supplementation from either no protein, serum from women with endometriosis or tubal infertility, fertile donor serum, or 15% SSS, and embryo development was assessed up to 96 hours; the authors reported no major caveat in the abstract regarding limitations. SSS supported substantially higher morula formation (64.9% at 48 hours) and blastocyst development (29.7% at 72 hours, 83.7% by 96 hours) than the serum conditions evaluated, and blastocyst hatching was observed in the SSS group (43.2% by 96 hours), with serum group hatching largely absent. In Experiment II with human IVF embryos, embryo stage/quality did not differ between SSS and serum, though fertilization rates tended to be higher with SSS (70.0% vs 55.0%, P=0.07). Relevance to endometriosis: the paper includes serum from women with endometriosis as one of the serum comparison groups in the mouse embryo experiments, finding that endometriosis serum performed worse than SSS for blastocyst development, though the paper’s main focus is comparing SSS versus serum for embryo culture.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
4,627 characters
· extracted from
oa-doi-fallback
· 4 sections
· click to expand
Abstract
Results
Conclusions
References
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (12)
- doi:10.1007/bf01133884 via openalex
- doi:10.1016/s0015-0282(16)56099-3 via openalex
- doi:10.1016/s0015-0282(16)56651-5 via openalex
- doi:10.1016/s0015-0282(16)53956-9 via openalex
- doi:10.1016/s0015-0282(16)47537-0 via openalex
- doi:10.1016/s0015-0282(16)48330-5 via openalex
- doi:10.1016/s0015-0282(16)48202-6 via openalex
- doi:10.1016/s0015-0282(16)49952-8 via openalex
- doi:10.1016/s0015-0282(16)60372-2 via openalex
- W652760124 via openalex
- W2403677318 via openalex
- doi:10.1016/s0015-0282(16)61035-x via openalex
Source provenance
- europepmc
- last seen: 2026-07-27T06:15:28.040536+00:00
- openalex
- last seen: 2026-05-11T06:15:24.675520+00:00
- pubmed
- last seen: 2026-05-13T22:11:08.331550+00:00
- unpaywall
- last seen: 2026-06-04T02:00:05.705006+00:00